Rheumatology/Arthritis Market Research Reports & Industry Analysis
Some evidence suggests that excessive immune responses may be due to glucocorticoid resistance in target tissues. For example, the number of glucocorticoid receptors in circulating leukocytes is decreased 50% in patients with RA. This decrease in receptors would prevent adequate suppression of leukocyte activity and could further enhance inflammation.Rheumatologists remain the most up-to-date health professionals in autoimmune disease treatment. Early intervention has been noted by nearly all in the field as the single most important factor in treatments and continued quality of life. New advancements in risk factors, diagnosis, and therapies have made it possible for rheumatologist to treat these conditions successfully with the best possible outcomes.
Successful treatment of autoimmune diseases have resulted from a growing array of therapies available to specialists. Symptomatic treatments have traditionally been used for patients with rheumatoid arthritis, lupus and other autoimmune disorders. While these treatments are still used regularly, new disease-modifying therapies have produced the most impressive results in treating these diseases. Additionally, combination therapies continue to grow in preference and offer exciting results in disease management.
Rheumatology/Arthritis Industry Research & Market Reports
-
Musculoskeletal Disorders Drugs Global Market Briefing 2023
... capita consumption, the market was $13.4 and in terms of global GDP, the market was 0.09%. Musculoskeletal disorders drugs was the sixth largest segment within the market accounting for 6.5% preceded and followed by cardiovascular ... Read More
-
Osteoarthritis Treatment Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... expected to show a short-term impact on the market growth as it had led to the cancelation or postponement of the scheduled treatment procedures along with a decrease in the number of new diagnoses and ... Read More
-
Rheumatoid Arthritis Therapeutics
... year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will ... Read More
-
Global Rheumatoid Arthritis Drugs Market Research Report 2022 - Market Size, Current Insights and Development Trends
... geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, enabling it ... Read More
-
Digital Health in Immunology Market Size, Share and Trends Analysis by Region, Product, Technology (Telemedicine, mHealth, Digital Therapeutics, Others), Therapy Area (Dermatology, Rheumatology, Gastroenterology) and Segment Forecast, 2022-2027
... market size was valued at US$6.0 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 24.2% during 2022-2027. The digital health in immunology market report provides an executive-level ... Read More
-
Auto-injectors Market, by Product Type (Prefilled Auto-injectors, Fillable Auto-injectors), by Disease Indication (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Others (Diabetes, Psoriasis, etc.)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Auto- injector is a medical device which can deliver dose of medications. Auto injectors are easy ... Read More
-
Rheumatoid Arthritis Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... had a significant impact on the rheumatoid arthritis drugs market as rheumatoid arthritis (RA) patients had a higher risk of COVID-19 infection. For instance, according to the study titled "Risk of COVID-19 in Rheumatoid Arthritis: ... Read More
-
Adalimumab Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... infectious-disease antibodies back in the spotlight. As per an article titled “Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients” published in March 2022, patients ... Read More
-
Global Rheumatoid Arthritis Therapeutics Market 2022 by Company, Regions, Type and Application, Forecast to 2028
... segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and ... Read More
-
Global Adalimumab Market - 2022-2029
... the forecast period (2022-2029). Adalimumab is approved under the brand name Humira for the treatment of Rheumatoid Arthritis (RA), Juvenile Idiopathic Arthritis (JIA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS), Crohn's Disease (CD), and Plaque Psoriasis ... Read More
-
Rheumatoid Arthritis Drugs Market Size, Share & Trends Report, 2022-2030
... that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis. The global Rheumatoid Arthritis Drugs market size will reach USD ... Read More
-
Methotrexate Drugs Market, by Treatment Type (Psoriasis, Rheumatoid Arthritis, Cancer), by Route of Administration (Oral, Injection), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Methotrexate is a type of disease-modifying anti-rheumatic drug (DMARD). It is used to reduce the activity of the immune ... Read More
-
Rheumatology Therapeutics
... projected to reach a revised size of US$54.5 Billion by 2027, growing at a CAGR of 2.6% over the analysis period 2020-2027. Disease Modifying Anti-Rheumatic Drugs (DMARDs), one of the segments analyzed in the report, ... Read More
-
Rheumatoid Arthritis Diagnosis Tests
... Million in the year 2020, is projected to reach a revised size of US$802.6 Million by 2027, growing at aCAGR of 4.8% over the period 2020-2027. Serology Tests, one of the segments analyzed in the ... Read More
-
TNF Inhibitors
... projected to reach a revised size of US$44 Billion by 2027, growing at a CAGR of 0.8% over the analysis period 2020-2027. Rheumatoid Arthritis, one of the segments analyzed in the report, is projected to ... Read More
-
Rheumatoid Arthritis Market Share, Size, Trends, Industry Analysis Report, By Therapy (Cell Therapy, DMARD, Symptomatic Treatment, Intermediate Corticosteroid Therapies); By Distribution Channel; By Drug Type; By Region; Segment Forecast, 2022 - 2030
... rheumatoid arthritis market size is expected to reach USD 33.30 billion by 2030, according to a new study by Polaris Market Research. The report “Rheumatoid Arthritis Market Share, Size, Trends, Industry Analysis Report, By Therapy ... Read More
-
Corticosteroids Therapy
... projected to reach a revised size of US$6.1 Billion by 2027, growing at aCAGR of 4.1% over the period 2020-2027. Glucocorticoids, one of the segments analyzed in the report, is projected to record 4.5% CAGR ... Read More
-
North America Prefilled Syringes Market Size, Share & Industry Trends Analysis Report By Application (Diabetes, Anaphylaxis, Rheumatoid Arthritis), By Therapeutics, By Material (Glass-based and Plastic-based), By Design, By Country and Growth Forecast, 2022 – 2028
... 2028 The North America Prefilled Syringes Market would witness market growth of 10.1% CAGR during the forecast period (2022-2028). Standard syringes include closely fitting glass rods as well as cylindrical glass barrels, which are substantially ... Read More
-
Global Prefilled Syringes Market Size, Share & Industry Trends Analysis Report By Application (Diabetes, Anaphylaxis, Rheumatoid Arthritis), By Therapeutics, By Material (Glass-based and Plastic-based), By Design, By Regional Outlook and Forecast, 2022 – 2028
... The Global Prefilled Syringes Market size is expected to reach $11.9 billion by 2028, rising at a market growth of 10.5% CAGR during the forecast period. A single-dose packet of vaccination attached with a needle ... Read More
-
Europe Prefilled Syringes Market Size, Share & Industry Trends Analysis Report By Application (Diabetes, Anaphylaxis, Rheumatoid Arthritis), By Therapeutics, By Material (Glass-based and Plastic-based), By Design, By Country and Growth Forecast, 2022 - 2028
... The Europe Prefilled Syringes Market would witness market growth of 10.0% CAGR during the forecast period (2022-2028). Innovative improvements like buried needles are crucial in the context of self-injection devices in minimizing such injuries, leading ... Read More
-
Global Adalimumab Market Research Report 2022 - Market Size, Current Insights and Development Trends
... spondylitis, Crohn's disease, ulcerative colitis, psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis. The report focuses on the Adalimumab market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and ... Read More
-
Stem Cell Therapy Market, by Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells, and Others), by Application (Musculoskeletal Disorders, Wounds and Injuries, Cancer, Autoimmune Disorders, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Stem cell therapy is a form of regenerative medicine designed to repair damaged cells within ... Read More
-
Musculoskeletal Disorders Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... terms of per capita consumption, the market was $12.7 and in terms of global GDP, the market was 0.11%. Musculoskeletal disorders drugs was the sixth largest segment within the market accounting for 6.7% preceded and ... Read More
-
Saudi Arabia Foot & Ankle Devices Market, By Product Type (Joint Implants, Fixation Devices, Soft Tissue Orthopedic Devices, Bracing & Support Devices, Prostheses), By Procedure (Osteotomy, Fracture Repair, Fusion Procedures, Others), By Application (Trauma & Hair line Fractures, Rheumatoid Arthritis & Osteoarthritis, Diabetic Foot Diseases, Ligament Injuries, Others), By End User (Hospitals, Ambulatory Surgery Centers, Orthopedic Clinics, Rehabilitation Centers), By Region, Competition Forecast & Opportunities, 2027
... & Hair line Fractures, Rheumatoid Arthritis & Osteoarthritis, Diabetic Foot Diseases, Ligament Injuries, Others), By End User (Hospitals, Ambulatory Surgery Centers, Orthopedic Clinics, Rehabilitation Centers), By Region, Competition Forecast & Opportunities, 2027 Saudi Arabia foot ... Read More
-
Superoxide Dismutase [Cu-Zn] (Superoxide Dismutase 1 or Epididymis Secretory Protein Li 44 or SOD1 or EC 1.15.1.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Update Summary According to the recently published report 'Superoxide Dismutase [Cu-Zn] - Drugs In Development, 2022'; Superoxide Dismutase [Cu-Zn] (Superoxide Dismutase 1 or Epididymis Secretory Protein Li 44 or SOD1 or EC 1.15.1.1) pipeline Target ... Read More
Research Assistance
